TUBERCULOSIS CONTROL

Abstract*

The Tuberculosis Control Project introduces a revised strategy for Tuberculosis control having the goal of reducing mortality, morbidity, and disability. The project's specific objectives will be to effectively treat about 1.9 million TB cases; achieve a 85 percent cure rate in the revised strategy districts; provide treatment with daily short-course chemotherapy and conventional drugs; and improve diagnosis, patient registration, and monitoring of... Show More

Development Objective

The Project's main objectives are:1) to improve the effectiveness of TB control by expanding the new DOTS (Directly-Observed Therapy, Short Course) strategy recommended by WHO;2) to reduce mortality, morbidity and disability due to TB; and3) to reduce the incidence of infectious TB by focusing on the cure of infectious patients.

Key Details

Project Details

Project ID
P010473
Status
Closed
Team Leader
Sadia Afroze Chowdhury
Borrower 2
N/A

Country
India
Disclosure Date
October 31, 1994
Approval Date
(as of board presentation)
January 30, 1997
Effective Date
May 8, 1997

Total Project Cost 1
US$ 142.40 million
Implementing Agency
N/A
Region
South Asia
Fiscal Year 3
1997

Commitment Amount
US$ 142.40 million
Environmental Category
C
Environmental and Social Risk
Not Applicable
Closing Date
March 31, 2006

Last Stage Reached
BANK APPROVED
Last Update Date
January 15, 2013

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control33%
- FY17 - Tuberculosis33%
FY17 - Health Systems and Policies33%
- FY17 - Health System Strengthening33%

FY17 - Social Development and Protection

FY17 - Social Inclusion34%
- FY17 - Indigenous People and Ethnic Minorities17%
- FY17 - Participation and Civic Engagement17%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
IDA Credit	142.40

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	N/A
IDA Commitment	142.40
IBRD + IDA Commitment	142.40

Lending Instrument
Grant Amount	N/A
Total Project Cost**	142.40

Summary Status of World Bank Financing (US$ Millions) as of April 30, 2025

No data available.

Detailed Financial Activity as of April 30, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Aug 1, 2017	IDA-29360	Int Charges	24,650.85
Aug 1, 2017	IDA-29360	Loan Repay	6,295,279.50
Aug 1, 2016	IDA-29360	Int Charges	338,672.16
Aug 1, 2016	IDA-29360	Int Charges	9,851.40
Aug 1, 2016	IDA-29360	Int Charges	9,851.40
Aug 1, 2016	IDA-29360	Loan Repay	3,114,220.80
Aug 1, 2016	IDA-29360	Int Charges	338,672.16
Feb 1, 2017	IDA-29360	Int Charges	295,252.60
Feb 1, 2017	IDA-29360	Int Charges	295,252.60
Feb 1, 2017	IDA-29360	Loan Repay	14,550.70
Feb 1, 2017	IDA-29360	Loan Repay	3,024,006.50
Feb 1, 2016	IDA-29360	Int Charges	15,586.09
Feb 1, 2016	IDA-29360	Int Charges	15,586.09
Feb 1, 2016	IDA-29360	Loan Repay	3,071,618.20
Feb 1, 2016	IDA-29360	Int Charges	335,841.03
Aug 1, 2019	IDA-29360	Loan Repay	6,106,722.50
Aug 1, 2019	IDA-29360	Int Charges	217,552.48
Aug 1, 2019	IDA-29360	Int Charges	217,552.48
Aug 1, 2019	IDA-29360	Int Charges	69,079.33
Feb 1, 2019	IDA-29360	Loan Repay	69,234.11
Feb 1, 2019	IDA-29360	Loan Repay	6,165,987.50
Feb 1, 2019	IDA-29360	Int Charges	174,979.39
Feb 1, 2019	IDA-29360	Int Charges	174,979.39
Aug 1, 2018	IDA-29360	Loan Repay	6,255,954.50
Aug 1, 2018	IDA-29360	Int Charges	269,788.53
Aug 1, 2018	IDA-29360	Int Charges	269,788.53
Aug 1, 2018	IDA-29360	Int Charges	169,114.62
Aug 1, 2018	IDA-29360	Int Charges	169,114.62
Feb 1, 2018	IDA-29360	Int Charges	131,545.90
Feb 1, 2018	IDA-29360	Int Charges	131,545.90
Feb 1, 2021	IDA-29360	Loan Repay	838,000.70
Feb 1, 2021	IDA-29360	Int Charges	145,866.00
Feb 1, 2021	IDA-29360	Int Charges	145,866.00
Feb 1, 2021	IDA-29360	Int Charges	100,809.21
Feb 1, 2021	IDA-29360	Int Charges	100,809.21
Feb 1, 2021	IDA-29360	Loan Repay	2,368,449.00
Aug 1, 2020	IDA-29360	Int Charges	19,121.97
Aug 1, 2020	IDA-29360	Int Charges	19,121.97
Aug 1, 2020	IDA-29360	Loan Repay	3,150,203.50
Aug 1, 2020	IDA-29360	Int Charges	78,158.63
Aug 1, 2020	IDA-29360	Int Charges	78,158.63
Feb 1, 2020	IDA-29360	Loan Repay	37,296.87
Feb 1, 2020	IDA-29360	Loan Repay	6,102,063.50
Feb 1, 2020	IDA-29360	Int Charges	177,059.38
Feb 1, 2020	IDA-29360	Int Charges	177,059.38
Aug 1, 2019	IDA-29360	Int Charges	69,079.33
Aug 1, 2023	IDA-29360	Int Charges	33,446.65
Aug 1, 2023	IDA-29360	Int Charges	33,446.65
Feb 1, 2023	IDA-29360	Loan Repay	110,989.78
Feb 1, 2023	IDA-29360	Loan Repay	5,877,666.00
Aug 1, 2022	IDA-29360	Loan Repay	5,903,030.00
Aug 1, 2022	IDA-29360	Int Charges	121,824.43
Aug 1, 2022	IDA-29360	Int Charges	121,824.43
Aug 1, 2022	IDA-29360	Loan Repay	3,587.66
Feb 1, 2022	IDA-29360	Loan Repay	38,270.15
Feb 1, 2022	IDA-29360	Loan Repay	3,078,248.20
Feb 1, 2022	IDA-29360	Int Charges	140,243.84
Feb 1, 2022	IDA-29360	Int Charges	140,243.84
Aug 1, 2021	IDA-29360	Int Charges	155,279.20
Aug 1, 2021	IDA-29360	Int Charges	155,279.20
Aug 1, 2021	IDA-29360	Int Charges	22,324.19
Aug 1, 2021	IDA-29360	Loan Repay	3,185,204.00
Aug 1, 2021	IDA-29360	Int Charges	22,324.19
Jan 30, 1997	IDA-29360	Loan Commitment	142,400,000.00
Feb 1, 2024	IDA-29360	Int Charges	44,590.91
Feb 1, 2024	IDA-29360	Int Charges	44,590.91
Aug 1, 2024	IDA-29360	Int Charges	23,608.72
Aug 1, 2017	IDA-29360	Int Charges	191,090.92
Aug 1, 2017	IDA-29360	Int Charges	191,090.92
Aug 1, 2017	IDA-29360	Int Charges	24,650.85
Aug 1, 2024	IDA-29360	Int Charges	23,608.72
Aug 1, 2024	IDA-29360	Loan Repay	15,234.30
Aug 1, 2024	IDA-29360	Loan Repay	5,895,574.50
Feb 1, 2024	IDA-29360	Loan Repay	5,925,121.00
Feb 1, 2024	IDA-29360	Int Charges	55,548.45
Feb 1, 2024	IDA-29360	Int Charges	55,548.45
Aug 1, 2023	IDA-29360	Loan Repay	37,082.44
Aug 1, 2023	IDA-29360	Int Charges	100,800.26
Aug 1, 2023	IDA-29360	Int Charges	100,800.26
Aug 1, 2023	IDA-29360	Loan Repay	5,973,319.50
Feb 1, 2014	IDA-29360	Int Charges	429,668.44
Feb 1, 2014	IDA-29360	Int Charges	429,668.44
Feb 1, 2014	IDA-29360	Int Charges	16,781.48
Feb 1, 2014	IDA-29360	Int Charges	16,781.48
Feb 1, 2014	IDA-29360	Loan Repay	1,710,120.60
Aug 1, 2013	IDA-29360	Int Charges	12,760.67
Aug 1, 2013	IDA-29360	Int Charges	12,760.67
Aug 1, 2013	IDA-29360	Loan Repay	1,683,714.10
Aug 1, 2013	IDA-29360	Int Charges	412,825.44
Aug 1, 2013	IDA-29360	Int Charges	412,825.44
Feb 1, 2016	IDA-29360	Int Charges	335,841.03
Aug 1, 2015	IDA-29360	Loan Repay	134,205.80
Aug 1, 2015	IDA-29360	Loan Repay	2,975,043.50
Aug 1, 2015	IDA-29360	Int Charges	345,673.80
Aug 1, 2015	IDA-29360	Int Charges	345,673.80
Feb 1, 2015	IDA-29360	Int Charges	377,150.16
Feb 1, 2015	IDA-29360	Int Charges	377,150.16
Feb 1, 2015	IDA-29360	Loan Repay	3,119,338.20
Feb 1, 2015	IDA-29360	Loan Repay	23,574.06
Aug 1, 2014	IDA-29360	Loan Repay	1,419.72
Aug 1, 2014	IDA-29360	Loan Repay	3,411,821.20
Aug 1, 2014	IDA-29360	Int Charges	422,389.28
Aug 1, 2014	IDA-29360	Int Charges	422,389.28
Feb 1, 2018	IDA-29360	Loan Repay	6,489,544.00
Feb 1, 2018	IDA-29360	Int Charges	128,768.76
Feb 1, 2018	IDA-29360	Int Charges	128,768.76

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Progress towards achievement of PDO	Satisfactory	2005-11-19
Project Management	Highly Satisfactory	2005-11-19
Financial Management	Satisfactory	2005-11-19
Counterpart Funding	Satisfactory	2005-11-19
Overall Implementation Progress (IP)	Satisfactory	2005-11-19
Overall Safeguards Rating	Satisfactory	2005-11-19
Monitoring and Evaluation	Highly Satisfactory	2005-11-19
Procurement	Satisfactory	2005-11-19

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

INDICATOR	ICR REVIEW: 09-20-2006	PROJECT PERFORMANCE ASSESSMENT REPORT:
Outcome Rating	Satisfactory	N/a
Risk To Development Outcome	Not Rated	N/a
Bank Performance	Satisfactory	N/a
Borrower Performance	Satisfactory	N/a
Government Performance	Satisfactory	N/a
Implementing Agency	Satisfactory	N/a
Icr Quality	Satisfactory	N/a
M&e Quality	Not Rated	N/a

Results Framework

No data available.

TUBERCULOSIS CONTROL

Abstract*

Development Objective

Key Details

Project Details

Sectors

Themes

Stay Connected, sign up for our:

Project Map

Finances

Financing Plan (US$ Millions)

Total Project Financing (US$ Millions)

Summary Status of World Bank Financing (US$ Millions) as of April 30, 2025

Detailed Financial Activity as of April 30, 2025

Ratings

IMPLEMENTATION RATINGS

COMPLETION RATINGS

INDEPENDENT EVALUATION RATINGS

Results Framework